Skip to main navigation Skip to search Skip to main content

An Open-Label, Uncontrolled, Multicenter, Multinational Study on the Efficacy and Safety of Administration of Donor Lymphocytes Depleted of Alloreactive T-Cells (ATIR), Through the Use of TH9402 and Light Treatment in an Ex Vivo Process, i

Project: Research

Project Details

StatusFinished
Effective start/end date10/18/1109/7/13

Funding

  • Kiadis Pharma Netherlands B V: $8,000.00